A recent study examined associations of comorbid migraine with other painful physical symptoms in patients with major depressive disorder at 2 years, and results suggested there might be benefit to integrating care for those with both depression and headache.
Researchers have identified a new target in the mitochondria of cancer cells that indicate the potential of a treatment class for certain blood cancers.
A recent study assessed patients’ preferred route of administering biologic drugs for severe asthma, as well as their related beliefs and preferences. The authors said convenience and efficacy beliefs about pharmaceuticals are important for physicians to understand in order to share decision making with patients.
Mental health disorders are rising in prevalence around the world and will cost the global economy $16 trillion by 2030. Here are 5 things about mental health during Mental Health Month this May.
Video telehealth pulmonary rehabilitation intervention reduced the risk of 30-day readmission in patients with chronic obstructive pulmonary disease.
HHS has announced that Gilead will donate its pre-exposure prophylaxis (PrEP) pill Truvada for up to 200,000 people in a multiyear agreement, just a day after the pharma giant announced that a generic version of the pill will come to market a year early. However, some activists are skeptic.
Bryan Chiang's concept lets a user take a photo of the eye using a special adapter on the smartphone; the image is then analyzed to predict blood glucose levels.
Proof-of-concept studies suggest the treatment that targets CD47 produces a strong response in patients with diffuse large B-cell lymphoma (DLBCL) with fewer adverse effects than current options.
This week, the top managed care news included HHS announcing a finalized rule requiring the disclosure of drug prices in television ads; a report finding high satisfaction with employer health coverage despite the cost; a study finding heart failure is surging among young adults.
Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
White patients are significantly more likely to be prescribed buprenorphine compared with patients of other races/ethnicities; Trump has backed a Florida proposal to import drugs from Canada; nearly 25% of medications approved in 2018 cost more than $30,000 per year.
Between 2004 and 2017, the annual number of fall-related fractures from walking leashed dogs increased from 1671 to 4396 among adults aged 65 years or older.
During an oral presentation of abstracts at the American Academy of Neurology’s 2019 Annual Meeting in Philadelphia, Pennsylvania, held May 4-10, researchers presented findings that suggest that while pregnant women with multiple sclerosis (MS) are often viewed as high-risk by their physician, pregnancy did not seem to increase the risk of adverse obstetrical outcomes for patients nor their babies.
During the American Thoracic Society’s Annual Meeting in Dallas, Texas, taking place May 17-22, 2019, researchers will present findings from a study investigating pirfenidone (Esbriet) in the treatment of idiopathic pulmonary fibrosis (IPF) in a real-world setting.
The FDA has approved amifampridine (Ruzurgi), the first treatment for pediatric patients with Lambert-Eaton myasthenic syndrome.
According to a recent study, hypoxia associated with episodes of upper airway obstruction in patients with obstructive sleep apnea syndrome may increase the levels of α‐synuclein in the blood and thus may contribute to the development of Parkinson disease.
President Trump today outlined a plan to tackle surprise medical billing and voiced his commitment to holding insurance companies and hospitals accountable.
Hospital prices of privately insured patients are more than twice the price that Medicare pays, according to a new report from RAND and supported by the Robert Wood Johnson Foundation, the National Institute for Health Care Reform, the Health Foundation of Greater Indianapolis, and participating employers.
Tennessee is set to become the first state to transition its Medicaid program to a block grant; a federal judge has blocked cuts to Medicare rates for 340B hospitals but did not grant permanent injunction; Senator Elizabeth Warren has unviled a plan to combat the opioid epidemic that would spend $100 billion over 10 years.
The number of patients requiring first-line chemotherapy is expected to increase by more than 50% from 2018 to 2040, and in order to deliver optimal treatment, a significant increase in the chemotherapy workforce is needed.
An analysis of adoption of and adherence to chronic obstructive pulmonary disease (COPD) Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines in the primary care setting unearthed disappointing results, finding suboptimal use of pulmonary function tests, no routine use of validated symptoms scales for diagnosis, and variation in pharmacotherapy.
Georgia Governor Brian Kemp signed a "heartbeat" abortion bill into law as legal battles over abortion continue across the nation; a new CDC study found that most pregnancy-related deaths could be prevented; lawyers of former NFL players are fighting a rule that limited retired players to attending physicians within 150 miles of their homes for dementia diagnoses.
The Trump administration on Wednesday announced a final rule requiring drug manufacturers to disclose drug prices in television ads for drugs covered by Medicare or Medicaid if the wholesale acquisition cost is $35 or more for a month’s supply.
According to Willis Towers Watson’s Health Care Access and Delivery Survey, a growing number of employers have implemented new strategies to provide their employees with increased access to high-quality, convenient, and affordable healthcare.
Bisphosphonates, which are used to treat osteoporosis and prevent fractures, are increasingly being used more effectively in a population more likely to benefit, according to results presented at ENDO 2019, the Endocrine Society’s annual meeting.
Witnesses appearing before the Senate Judiciary Committee discussed the need to maintain innovation for new drug discoveries while ensuring patients have access to treatments for chronic diseases as well as potentially curative therapies. In addition, Senator John Cornyn, R-Texas, raised the idea of giving the Federal Trade Commission (FTC) more authority to cut through patent thickets; his office said later he will propose a bill doing just that.
Researchers from the University of Buffalo surveyed pharmacist students, finding high awareness of pre-exposure prophylaxis (PrEP) and generally positive attitudes towards it. However, the survey also revelaed gaps in knowledge, highlighting the need for more education.
Rates of low birth weight and premature birth are higher in the United States than most other developed nations, and these factors are believed to contribute to nearly 36% of infant mortality. A recent study sought to evaluate whether Medicaid expansion was associated with changes in rates of low birth weight and preterm outcomes, both overall and by race/ethnicity.
The use of the circulating tumor DNA workflow demonstrated a proof of concept for this system of guiding treatment in the most common form of ovarian cancer.
